Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Leukemia"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin Followed By High-Dose Cytarabine Followed By Either Gemtuzumab Ozogamicin or No Additional Therapy in Treating Patients With Previously Untreated De Novo Acute Myeloid Leukemia Steven Edward Coutre
 Leukemia
Phase II Intergroup Clinical Trial For Adolescents & Young Adults With Untreated ALL Michaela Liedtke
 Leukemia
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) Laura Johnston
 Leukemia, Myelocytic, Acute
Myelodysplastic Syndromes
Study to Assess Compliance With Long-Term MercaptopurineTreatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Dr. Neyssa Marina
 Leukemia
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Dr. Neyssa Marina
 Leukemia
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes Dr. Neyssa Marina
 Leukemia
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia Dr. Neyssa Marina
 Leukemia
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) Clare J. Twist M.D.
 Leukemia, Lymphocytic, Acute
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Dr. Neyssa Marina
 Leukemia
Myelodysplastic Syndromes
Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia Dr. Neyssa Marina
 Leukemia
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia Gary V Dahl
 Leukemia
Leukemia, Myeloid
Imatinib Mesylate and Nilotinib After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia Laura Johnston
 Leukemia


Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia Norman James Lacayo
 Leukemia
Study of Late-Occurring Complications in Childhood Cancer Survivors Dr. Neyssa Marina
 Leukemia
Sarcoma
Retinoblastoma
Lymphoma
Retinal Neoplasms
Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer Shelli Kesler
 Brain Cancer
Carcinomas (including Squamous Cell and Adenocarcinoma)
Leukemia, Lymphocytic, Acute
Bone Marrow Grafting for Leukemia and Lymphoma Robert S Negrin
David Miklos
 Leukemia
Lymphoma
Hematologic Diseases
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Dr. Neyssa Marina
 Leukemia
Research Sample Repository for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation Robert S Negrin
Judith Anne Shizuru
 Leukemia, Myeloid
Lymphoma, Non-Hodgkin
Multiple Myeloma
NMDP Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation David Miklos
 Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic
Multiple Myeloma
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Dr. Neyssa Maria Marina
 Leukemia

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting) 		Dr. Neyssa Marina
 Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
(No longer recruiting) 		Gary V Dahl
 Leukemia
Lymphoma
Tumor Lysis Syndrome
Hyperuricemia
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
(No longer recruiting) 		Gary V Dahl
 Leukemia, Myelocytic, Acute
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
(No longer recruiting) 		Dr. Neyssa Marina
 Leukemia
Myelodysplastic Syndromes
Allogeneic Transplantation for Patients with Acute Leukemia or CML
(No longer recruiting) 		Ginna Laport
 Leukemia, Lymphocytic, Acute
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
(Suspended) 		Dr. Neyssa Marina
 Leukemia
Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia
(Completed) 		Gary V Dahl
 Leukemia, T-Cell
Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
(Suspended) 		Dr. Neyssa Marina
 Leukemia


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: